It highlights the potential involvement of BDNF dysregulation in the pathophysiology of panic disorder and suggests that targeting BDNF pathways may hold promise for the development of novel therapeutic interventions (Deng et al., 2016). The gene discussed is BDNF; the disease is panic disorder.